Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Joao Passos (Newcastle upon Tyne, United Kingdom). Mitochondrial dysfunction in chronic lung disease. International Congress 2016 – Dysfunctional mitochondria in respiratory disease

Member's Comments

No comment yet.

Related content which might interest you: Mitochondrial dysfunction in lung ageing and disease Source: Eur Respir Rev, 29 (157) 200165; 10.1183/16000617.0165-2020 Year: 2020 Lung fibrosis - a disease of mitochondrial dysfunction Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease Year: 2018 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Prediction of chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003 Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Generalized muscle dysfunction in COPD and chronic heart failure independent of disease severity Source: Eur Respir J 2001; 18: Suppl. 33, 183s Year: 2001 Lysosomal dysfunction in COPD pathogenesis. Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Respiratory muscle senescence during chronic lung disease and ageing Source: ERS Lung Science Conference 2020 Year: 2020 Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011 Mechanisms of development oxidative stress and progression chronic respiratory failure in patients with COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Management of tuberculosis in patients with chronic liver dysfunction Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007